Nazzareno Dimasi

A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy

John Y. Li, Samuel R. Perry, Vanessa Muniz‐Medina et al. · Cancer Cell · 2016 · 390 citations · Full text

Medicine, Oncology, Pharmacology +14

A multifunctional bispecific antibody protects against <i>Pseudomonas aeruginosa</i>

Antonio DiGiandomenico, Ashley Keller, Cuihua Gao et al. · Science Translational Medicine · 2014 · 280 citations

Pharmacy, Infectious Diseases, Microbiology +14

Crystal Structure of a Superantigen Bound to the High-Affinity, Zinc-Dependent Site on MHC Class II

Yili Li, Hongmin Li, Nazzareno Dimasi et al. · Immunity · 2001 · 135 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Variable MHC class I engagement by Ly49 natural killer cell receptors demonstrated by the crystal structure of Ly49C bound to H-2Kb

Julie Dam, Rongjin Guan, Kannan Natarajan et al. · Nature Immunology · 2003 · 134 citations

Life Sciences, Immunology, Molecular Biology +16

Antibody–Drug Conjugates Bearing Pyrrolobenzodiazepine or Tubulysin Payloads Are Immunomodulatory and Synergize with Multiple Immunotherapies

Jonathan Rios‐Doria, Jay Harper, Raymond Rothstein et al. · Cancer Research · 2017 · 134 citations

Medicine, Immunology, Pharmacology +17